Cargando…
Hereditary leiomyomatosis and renal cell cancer (HLRCC): A case report
Hereditary leiomyomatosis and renal cell cancer is a rare, inherited disease caused by mutations in the fumarate hydratase gene. It is characterized by cutaneous leiomyomas, uterine leiomyomas, and/or renal cell cancer. We present the case of a 42-year-old woman with a heterozygous missense mutation...
Autores principales: | Yonamine, Tomoko, Kaname, Tadashi, Chinen, Yasutsugu, Tamashiro, Kouichi, Kosuge, Noritake, Saito, Seiichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052518/ https://www.ncbi.nlm.nih.gov/pubmed/32154112 http://dx.doi.org/10.1016/j.eucr.2020.101141 |
Ejemplares similares
-
Complete Response of Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC)-Associated Renal Cell Carcinoma to Pembrolizumab Immunotherapy: A Case Report
por: Wang, Tao, et al.
Publicado: (2021) -
Hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome in a young patient presenting with a large uterus: A case report and review of the literature
por: Shero, Nora, et al.
Publicado: (2023) -
Rare variant in the fumarate hydratase gene found in patients with clinical features of hereditary leiomyomatosis and renal cell cancer (HLRCC): A case series
por: Franke, Keith, et al.
Publicado: (2022) -
Response to Combination of Pembrolizumab and Axitinib in Hereditary Leyomiomatosis and Renal Cell Cancer (HLRCC)
por: Gurruchaga Sotés, Ibon, et al.
Publicado: (2021) -
Hereditary Leiomyomatosis and Renal Cell Cancer: Recent Insights Into Mechanisms and Systemic Treatment
por: Zhang, Congwang, et al.
Publicado: (2021)